North Capital, Inc. Bio Rad Laboratories, Inc. Transaction History
North Capital, Inc.
- $106 Billion
- Q1 2025
A detailed history of North Capital, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, North Capital, Inc. holds 3 shares of BIO stock, worth $726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$726% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
472Shares Held
18.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$376 Million0.01% of portfolio
-
Veritas Asset Management LLP977KShares$237 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$181 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$175 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.97B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...